Firm News: Drugs & Devices: Page 7

Weitz & Luxenberg is now accepting cases involving injuries from the nonsurgical permanent birth control device Essure. After implantation, a woman visits her physician three months later for a follow-up exam to confirm device placement. The law firm is interested in talking to those implanted with Essure devices who went to their follow-up doctor visit,…

W&L of counsel attorney Ellen Relkin will deliver a law update on Thursday, April 7, at Boardwalk Seminar 2016. Boardwalk Seminar 2016 is sponsored by the New Jersey Association for Justice. The event will be held over three days, beginning Wednesday, April 6, at Harrah’s Resort in Atlantic City, New Jersey. A certified New Jersey civil…

When physicians prescribe antibiotics to patients, they don’t expect their patients to develop a problem with their aorta. However, patients taking the fluoroquinolone class of antibiotics may do just that, based on elevated risk estimates found in two studies recently published in medical journals. W&L is now accepting clients who have suffered aortic dissection or…

On January 4, the U.S. Food and Drug Administration (FDA) strengthened requirements governing surgical mesh for the transvaginal repair of pelvic organ prolapse (POP). W&L hails this action as vital to addressing safety risks posed by transvaginal mesh devices. “Previously, transvaginal mesh products were classified as Class II moderate-risk medical devices, but the FDA has…

On November 18, 2015, U.S. District Judge Kathryn H. Vratil of Kansas appointed the first plaintiffs steering committee (PSC) in a federal multidistrict litigation (MDL) with a majority of women members. This is a significant and appropriate achievement given that women comprise a large segment of the lawyers in the United States and about 50…